GlassScriptPhysician profile
Itai Ronen
NPI 1376994905
$7,706.41
in general payments reported to CMS, 2019-2025
28 companies · $412 in 2025
The $412 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $73.75 · 2021: $239 · 2022: $4,950 · 2023: $341 · 2024: $691 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,709.36 | 2019-2022 | |
| Shield Therapeutics INC | $290.51 | 2022-2025 | Accrufer |
| Abbvie INC. | $235.40 | 2020-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Pfizer INC. | $231.76 | 2021-2025 | |
| Biogen, INC. | $196.72 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $128.70 | 2024-2025 | Myfembree |
| Exeltis, USA INC. | $117.85 | 2020-2025 | Slynd |
| Mayne Pharma Commercial LLC | $116.33 | 2021-2024 | |
| Astellas Pharma US INC | $105.81 | 2023-2024 | Veozah |
| Millicent US INC | $72.09 | 2023-2024 | Intrarosa, Femring |
| Hologic Sales and Service, LLC | $63.05 | 2022-2024 | Thinprep 2000 Processor, Aptima |
| Evofem Biosciences, INC. | $44.99 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mimedx Group, INC. | $42.48 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.03 | 2021 | |
| Therapeuticsmd, INC. | $34.90 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $34.81 | 2024 | Irrisept |
| Exact Sciences Corporation | $31.14 | 2024 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $27.25 | 2023 | Balcoltra |
| Ethicon US, LLC | $23.70 | 2024 | Stratafix, Ethicon, Dermabond |
| Scynexis, INC. | $23.50 | 2022 | |
| Mylan Pharmaceuticals INC. | $22.67 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.33 | 2024 | Exparel |
| Dysis Medical, INC. | $18.57 | 2023 | Dysis V3 Digital Coploscope, Dysis Ultra 2.0, Dysis View |
| Aspira Women'S Health INC | $17.98 | 2024 | Ova1 |
| Cranial Technologies, INC | $15.55 | 2020 | |
| Ascend Therapeutics US, LLC | $14.92 | 2023 | |
| Amneal Pharmaceuticals LLC | $14.64 | 2023 | Unithroid |
| Coopersurgical, INC. | $14.37 | 2023 | Summit Doppler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itai Ronen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.